“…116,117 According to ESPEN guidelines on definitions and terminology of clinical nutrition, chronic DRM is commonly described in patients with chronic HF defining it as nonintentional and non-edematous weight loss >7.5% of the premorbid normal weight. 1 Patients with terminal HF are the most complex population with multiple comorbidities and multiple organ dysfunction affecting appetite, intestinal absorption, aerobic metabolism, immunocompetency, neurohormonal axis, as well as protein and enzyme production at cell level. 69,72,118 Whether alone or in combination, micronutrient supplementation improves outcomes of patients with HF by ameliorating symptoms, work capacity, and left ventricular ejection fraction, thus increasing the quality of life.…”